Global Female Contraceptive Market Insights, Forecast to 2025

Publisher Name :
Date: 09-May-2019
No. of pages: 117
Inquire Before Buying

Female contraceptives, also known as female birth control are methods of preventing pregnancy that primarily involve the female physiology.

Female contraceptive devices account for major shares of the contraceptive pills market throughout the forecast period. The increasing adoption of female contraceptive devices will drive the growth of this product segment in the female contraceptive market.

The Americas will be the major revenue contributor to the contraceptive pills market throughout the forecast period. In this region, US will be the major contributor owing to the increased demand and adoption of female contraceptive devices.

The global Female Contraceptive market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Female Contraceptive market based on company, product type, end user and key regions.

This report studies the global market size of Female Contraceptive in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Female Contraceptive in these regions.

This research report categorizes the global Female Contraceptive market by top players/brands, region, type and end user. This report also studies the global Female Contraceptive market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Merck

- Pfizer

- Allergan

- Bayer

- Okamoto Industries

- Reckitt Benckiser

- Lupin Pharmaceuticals

- Foundation Consumer Healthcare

- Teva Pharmaceuticals

- Ansell

- Ferring Pharmaceuticals

- Fuji Latex

- Janssen Pharmaceuticals

Market size by Product

- Female Contraceptive Devices

- Female Contraceptive Drugs

Market size by End User

- Online Stores

- Retail Outlets

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Female Contraceptive market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Female Contraceptive market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Female Contraceptive companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Female Contraceptive submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Female Contraceptive are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Female Contraceptive market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Female Contraceptive Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Female Contraceptive Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Female Contraceptive Market Size Growth Rate by Product
1.4.2 Female Contraceptive Devices
1.4.3 Female Contraceptive Drugs
1.5 Market by End User
1.5.1 Global Female Contraceptive Market Size Growth Rate by End User
1.5.2 Online Stores
1.5.3 Retail Outlets
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Female Contraceptive Market Size
2.1.1 Global Female Contraceptive Revenue 2014-2025
2.1.2 Global Female Contraceptive Sales 2014-2025
2.2 Female Contraceptive Growth Rate by Regions
2.2.1 Global Female Contraceptive Sales by Regions
2.2.2 Global Female Contraceptive Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Female Contraceptive Sales by Manufacturers
3.1.1 Female Contraceptive Sales by Manufacturers
3.1.2 Female Contraceptive Sales Market Share by Manufacturers
3.1.3 Global Female Contraceptive Market Concentration Ratio (CR5 and HHI)
3.2 Female Contraceptive Revenue by Manufacturers
3.2.1 Female Contraceptive Revenue by Manufacturers (2014-2019)
3.2.2 Female Contraceptive Revenue Share by Manufacturers (2014-2019)
3.3 Female Contraceptive Price by Manufacturers
3.4 Female Contraceptive Manufacturing Base Distribution, Product Types
3.4.1 Female Contraceptive Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Female Contraceptive Product Type
3.4.3 Date of International Manufacturers Enter into Female Contraceptive Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Female Contraceptive Sales by Product
4.2 Global Female Contraceptive Revenue by Product
4.3 Female Contraceptive Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Female Contraceptive Breakdown Data by End User
6 North America
6.1 North America Female Contraceptive by Countries
6.1.1 North America Female Contraceptive Sales by Countries
6.1.2 North America Female Contraceptive Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Female Contraceptive by Product
6.3 North America Female Contraceptive by End User
7 Europe
7.1 Europe Female Contraceptive by Countries
7.1.1 Europe Female Contraceptive Sales by Countries
7.1.2 Europe Female Contraceptive Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Female Contraceptive by Product
7.3 Europe Female Contraceptive by End User
8 Asia Pacific
8.1 Asia Pacific Female Contraceptive by Countries
8.1.1 Asia Pacific Female Contraceptive Sales by Countries
8.1.2 Asia Pacific Female Contraceptive Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Female Contraceptive by Product
8.3 Asia Pacific Female Contraceptive by End User
9 Central & South America
9.1 Central & South America Female Contraceptive by Countries
9.1.1 Central & South America Female Contraceptive Sales by Countries
9.1.2 Central & South America Female Contraceptive Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Female Contraceptive by Product
9.3 Central & South America Female Contraceptive by End User
10 Middle East and Africa
10.1 Middle East and Africa Female Contraceptive by Countries
10.1.1 Middle East and Africa Female Contraceptive Sales by Countries
10.1.2 Middle East and Africa Female Contraceptive Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Female Contraceptive by Product
10.3 Middle East and Africa Female Contraceptive by End User
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Company Business Overview
11.1.3 Merck Female Contraceptive Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Merck Female Contraceptive Products Offered
11.1.5 Merck Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Company Business Overview
11.2.3 Pfizer Female Contraceptive Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Pfizer Female Contraceptive Products Offered
11.2.5 Pfizer Recent Development
11.3 Allergan
11.3.1 Allergan Company Details
11.3.2 Company Business Overview
11.3.3 Allergan Female Contraceptive Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Allergan Female Contraceptive Products Offered
11.3.5 Allergan Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Company Business Overview
11.4.3 Bayer Female Contraceptive Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Bayer Female Contraceptive Products Offered
11.4.5 Bayer Recent Development
11.5 Okamoto Industries
11.5.1 Okamoto Industries Company Details
11.5.2 Company Business Overview
11.5.3 Okamoto Industries Female Contraceptive Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Okamoto Industries Female Contraceptive Products Offered
11.5.5 Okamoto Industries Recent Development
11.6 Reckitt Benckiser
11.6.1 Reckitt Benckiser Company Details
11.6.2 Company Business Overview
11.6.3 Reckitt Benckiser Female Contraceptive Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Reckitt Benckiser Female Contraceptive Products Offered
11.6.5 Reckitt Benckiser Recent Development
11.7 Lupin Pharmaceuticals
11.7.1 Lupin Pharmaceuticals Company Details
11.7.2 Company Business Overview
11.7.3 Lupin Pharmaceuticals Female Contraceptive Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Lupin Pharmaceuticals Female Contraceptive Products Offered
11.7.5 Lupin Pharmaceuticals Recent Development
11.8 Foundation Consumer Healthcare
11.8.1 Foundation Consumer Healthcare Company Details
11.8.2 Company Business Overview
11.8.3 Foundation Consumer Healthcare Female Contraceptive Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Foundation Consumer Healthcare Female Contraceptive Products Offered
11.8.5 Foundation Consumer Healthcare Recent Development
11.9 Teva Pharmaceuticals
11.9.1 Teva Pharmaceuticals Company Details
11.9.2 Company Business Overview
11.9.3 Teva Pharmaceuticals Female Contraceptive Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Teva Pharmaceuticals Female Contraceptive Products Offered
11.9.5 Teva Pharmaceuticals Recent Development
11.10 Ansell
11.10.1 Ansell Company Details
11.10.2 Company Business Overview
11.10.3 Ansell Female Contraceptive Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Ansell Female Contraceptive Products Offered
11.10.5 Ansell Recent Development
11.11 Ferring Pharmaceuticals
11.12 Fuji Latex
11.13 Janssen Pharmaceuticals
12 Future Forecast
12.1 Female Contraceptive Market Forecast by Regions
12.1.1 Global Female Contraceptive Sales Forecast by Regions 2019-2025
12.1.2 Global Female Contraceptive Revenue Forecast by Regions 2019-2025
12.2 Female Contraceptive Market Forecast by Product
12.2.1 Global Female Contraceptive Sales Forecast by Product 2019-2025
12.2.2 Global Female Contraceptive Revenue Forecast by Product 2019-2025
12.3 Female Contraceptive Market Forecast by End User
12.4 North America Female Contraceptive Forecast
12.5 Europe Female Contraceptive Forecast
12.6 Asia Pacific Female Contraceptive Forecast
12.7 Central & South America Female Contraceptive Forecast
12.8 Middle East and Africa Female Contraceptive Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Female Contraceptive Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Female Contraceptive Product Picture
Table Female Contraceptive Market Segments
Table Key Manufacturers Female Contraceptive Covered
Table Global Female Contraceptive Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Female Contraceptive Sales Market Share by Product 2014-2025
Figure Female Contraceptive Devices Product Picture
Table Major Manufacturers of Female Contraceptive Devices
Figure Female Contraceptive Drugs Product Picture
Table Major Manufacturers of Female Contraceptive Drugs
Table Global Female Contraceptive Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Online Stores
Figure Retail Outlets
Figure Female Contraceptive Report Years Considered
Figure Global Female Contraceptive Market Size 2014-2025 (Million US$)
Figure Global Female Contraceptive Sales 2014-2025 (K Units)
Table Global Female Contraceptive Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Female Contraceptive Sales by Regions 2014-2019 (K Units)
Table Global Female Contraceptive Sales Market Share by Regions 2014-2019
Figure Global Female Contraceptive Sales Market Share by Regions 2014-2019
Figure 2018 Global Female Contraceptive Sales Market Share by Regions
Table Global Female Contraceptive Revenue by Regions 2014-2019 (Million US$)
Table Global Female Contraceptive Revenue Market Share by Regions 2014-2019
Figure Global Female Contraceptive Revenue Market Share by Regions 2014-2019
Figure 2018 Global Female Contraceptive Revenue Market Share by Regions
Table Global Female Contraceptive Sales by Manufacturers (2014-2019) (K Units)
Table Global Female Contraceptive Sales Share by Manufacturers (2014-2019)
Figure Global Female Contraceptive Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Female Contraceptive Revenue by Manufacturers (2014-2019) (Million USD)
Table Female Contraceptive Revenue Share by Manufacturers (2014-2019)
Figure Female Contraceptive Value Share by Manufacturers in 2018
Table Key Manufacturers Female Contraceptive Price (2014-2019) (USD/Unit)
Table Female Contraceptive Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Female Contraceptive Product Type
Table Date of International Manufacturers Enter into Female Contraceptive Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Female Contraceptive Sales by Product (2014-2019) (K Units)
Table Global Female Contraceptive Sales Share by Product (2014-2019)
Figure Global Female Contraceptive Sales Market Share by Product (2014-2019)
Figure Global Female Contraceptive Sales Market Share by Product in 2018
Table Global Female Contraceptive Revenue by Product (2014-2019) (Million US$)
Table Global Female Contraceptive Revenue Share by Product (2014-2019)
Figure Global Female Contraceptive Revenue Market Share by Product (2014-2019)
Figure Global Female Contraceptive Revenue Market Share by Product in 2018
Table Female Contraceptive Price by Product 2014-2019 (USD/Unit)
Table Global Female Contraceptive Sales by End User (2014-2019) (K Units)
Table Global Female Contraceptive Sales Share by End User (2014-2019)
Figure Global Sales Female Contraceptive Market Share by End User (2014-2019)
Figure Global Sales Female Contraceptive Market Share by End User in 2018
Figure North America Female Contraceptive Sales Growth Rate 2014-2019 (K Units)
Figure North America Female Contraceptive Revenue Growth Rate 2014-2019 (Million US$)
Table North America Female Contraceptive Sales by Countries (2014-2019) (K Units)
Table North America Female Contraceptive Sales Market Share by Countries (2014-2019)
Figure 2018 North America Female Contraceptive Sales Market Share by Countries
Table North America Female Contraceptive Revenue by Countries (2014-2019) (Million US$)
Table North America Female Contraceptive Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Female Contraceptive Revenue Market Share by Countries
Figure United States Female Contraceptive Sales Growth Rate (2014-2019) (K Units)
Figure United States Female Contraceptive Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Female Contraceptive Sales Growth Rate (2014-2019) (K Units)
Figure Canada Female Contraceptive Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Female Contraceptive Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Female Contraceptive Revenue Growth Rate (2014-2019) (Million US$)
Table North America Female Contraceptive Sales by Product (2014-2019) (K Units)
Table North America Female Contraceptive Sales Market Share by Product (2014-2019)
Figure 2018 North America Female Contraceptive Market Share by Product
Table North America Female Contraceptive Sales by End User (2014-2019) (K Units)
Table North America Female Contraceptive Sales Market Share by End User (2014-2019)
Figure 2018 North America Female Contraceptive Market Share by End User
Figure Europe Female Contraceptive Sales Growth Rate 2014-2019 (K Units)
Figure Europe Female Contraceptive Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Female Contraceptive Sales by Countries (2014-2019) (K Units)
Table Europe Female Contraceptive Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Female Contraceptive Sales Market Share by Countries
Table Europe Female Contraceptive Revenue by Countries (2014-2019) (Million US$)
Table Europe Female Contraceptive Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Female Contraceptive Revenue Market Share by Countries
Figure Germany Female Contraceptive Sales Growth Rate (2014-2019) (K Units)
Figure Germany Female Contraceptive Revenue Growth Rate (2014-2019) (Million US$)
Figure France Female Contraceptive Sales Growth Rate (2014-2019) (K Units)
Figure France Female Contraceptive Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Female Contraceptive Sales Growth Rate (2014-2019) (K Units)
Figure UK Female Contraceptive Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Female Contraceptive Sales Growth Rate (2014-2019) (K Units)
Figure Italy Female Contraceptive Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Female Contraceptive Sales Growth Rate (2014-2019) (K Units)
Figure Russia Female Contraceptive Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Female Contraceptive Sales by Product (2014-2019) (K Units)
Table Europe Female Contraceptive Sales Market Share by Product (2014-2019)
Figure 2018 Europe Female Contraceptive Market Share by Product
Table Europe Female Contraceptive Sales by End User (2014-2019) (K Units)
Table Europe Female Contraceptive Sales Market Share by End User (2014-2019)
Figure 2018 Europe Female Contraceptive Market Share by End User
Figure Asia Pacific Female Contraceptive Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Female Contraceptive Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Female Contraceptive Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Female Contraceptive Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Female Contraceptive Sales Market Share by Countries
Table Asia Pacific Female Contraceptive Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Female Contraceptive Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Female Contraceptive Revenue Market Share by Countries
Figure China Female Contraceptive Sales Growth Rate (2014-2019) (K Units)
Figure China Female Contraceptive Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Female Contraceptive Sales Growth Rate (2014-2019) (K Units)
Figure Japan Female Contraceptive Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Female Contraceptive Sales Growth Rate (2014-2019) (K Units)
Figure Korea Female Contraceptive Revenue Growth Rate (2014-2019) (Million US$)
Figure India Female Contraceptive Sales Growth Rate (2014-2019) (K Units)
Figure India Female Contraceptive Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Female Contraceptive Sales Growth Rate (2014-2019) (K Units)
Figure Australia Female Contraceptive Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Female Contraceptive Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Female Contraceptive Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Female Contraceptive Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Female Contraceptive Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Female Contraceptive Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Female Contraceptive Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Female Contraceptive Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Female Contraceptive Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Female Contraceptive Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Female Contraceptive Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Female Contraceptive Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Female Contraceptive Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Female Contraceptive Sales by Product (2014-2019) (K Units)
Table Asia Pacific Female Contraceptive Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Female Contraceptive Market Share by Product
Table Asia Pacific Female Contraceptive Sales by End User (2014-2019) (K Units)
Table Asia Pacific Female Contraceptive Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Female Contraceptive Market Share by End User
Figure Central & South America Female Contraceptive Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Female Contraceptive Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Female Contraceptive Sales by Countries (2014-2019) (K Units)
Table Central & South America Female Contraceptive Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Female Contraceptive Sales Market Share by Countries
Table Central & South America Female Contraceptive Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Female Contraceptive Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Female Contraceptive Revenue Market Share by Countries
Figure Brazil Female Contraceptive Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Female Contraceptive Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Female Contraceptive Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Female Contraceptive Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Female Contraceptive Sales by Product (2014-2019) (K Units)
Table Central & South America Female Contraceptive Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Female Contraceptive Market Share by Product
Table Central & South America Female Contraceptive Sales by End User (2014-2019) (K Units)
Table Central & South America Female Contraceptive Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Female Contraceptive Market Share by End User
Figure Middle East and Africa Female Contraceptive Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Female Contraceptive Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Female Contraceptive Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Female Contraceptive Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Female Contraceptive Sales Market Share by Countries
Table Middle East and Africa Female Contraceptive Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Female Contraceptive Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Female Contraceptive Revenue Market Share by Countries
Figure GCC Countries Female Contraceptive Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Female Contraceptive Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Female Contraceptive Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Female Contraceptive Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Female Contraceptive Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Female Contraceptive Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Female Contraceptive Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Female Contraceptive Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Female Contraceptive Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Female Contraceptive Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Female Contraceptive Market Share by Product
Table Middle East and Africa Female Contraceptive Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Female Contraceptive Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Female Contraceptive Market Share by End User
Table Merck Company Details
Table Merck Female Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Recent Development
Table Pfizer Company Details
Table Pfizer Female Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Allergan Company Details
Table Allergan Female Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Allergan Recent Development
Table Bayer Company Details
Table Bayer Female Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer Recent Development
Table Okamoto Industries Company Details
Table Okamoto Industries Female Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Okamoto Industries Recent Development
Table Reckitt Benckiser Company Details
Table Reckitt Benckiser Female Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Reckitt Benckiser Recent Development
Table Lupin Pharmaceuticals Company Details
Table Lupin Pharmaceuticals Female Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Lupin Pharmaceuticals Recent Development
Table Foundation Consumer Healthcare Company Details
Table Foundation Consumer Healthcare Female Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Foundation Consumer Healthcare Recent Development
Table Teva Pharmaceuticals Company Details
Table Teva Pharmaceuticals Female Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Teva Pharmaceuticals Recent Development
Table Ansell Company Details
Table Ansell Female Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Ansell Recent Development
Table Ferring Pharmaceuticals Company Details
Table Fuji Latex Company Details
Table Janssen Pharmaceuticals Company Details
Table Global Female Contraceptive Sales Forecast by Regions 2019-2025 (K Units)
Table Global Female Contraceptive Sales Market Share Forecast by Regions 2019-2025
Table Global Female Contraceptive Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Female Contraceptive Revenue Market Share Forecast by Regions 2019-2025
Table Global Female Contraceptive Sales Forecast by Product 2019-2025 (K Units)
Table Global Female Contraceptive Sales Market Share Forecast by Product 2019-2025
Table Global Female Contraceptive Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Female Contraceptive Revenue Market Share Forecast by Product 2019-2025
Table Global Female Contraceptive Sales Forecast by End User 2019-2025 (K Units)
Table Global Female Contraceptive Sales Market Share Forecast by End User 2019-2025
Figure North America Female Contraceptive Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Female Contraceptive Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Female Contraceptive Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Female Contraceptive Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Female Contraceptive Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Female Contraceptive Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Female Contraceptive Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Female Contraceptive Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Female Contraceptive Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Female Contraceptive Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Female Contraceptive Value Chain
Table Female Contraceptive Customers List
Table Female Contraceptive Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs